Fig. 1a (MTZ 30μM) / Fig. 1b (MTZ 30μM) / Fig.1d (MTZ30μM) / Fig. 2a (MTZ 3μM) / Fig. 2b (MTZ 10μM) / Fig.2d (MTZ 10μM) / Fig. 4a (control) / Fig. 4b (mepyramine 30μM) / Fig.4d (mepyramine 100μM) / Fig. 5b (methylhistaprodifen 10μM)
The early parts of the lines are identical from −50 to 10 min in these ten graphs.
The experimental conditions are as below. See also the table in the bottom right corner in the illustration.
Closed triangles in Fig. 1a (MTZ 30μM): serotonin level in DRN, mirtazapine 30μM in DRN from 0 to 120 min
Closed triangles in Fig. 1b (MTZ 30μM): serotonin level in FC, mirtazapine 30μM in DRN from 0 to 120 min
Closed triangles in Fig. 1d (MTZ 30μM): serotonin level in EC, mirtazapine 30μM in MRN from 0 to 120 min
Closed circles in Fig. 2a (MTZ 3μM): serotonin level in DRN, WAY 100635 in DRN from −60 to 120 min, mirtazapine 3μM in DRN from 0 to 120 min
Closed triangles in Fig. 2b (MTZ 10μM): serotonin level in FC, WAY 100635 in DRN from −60 to 120 min, mirtazapine 10μM in DRN from 0 to 120 min
Closed triangles in Fig. 2d (MTZ 10μM): serotonin level in EC, WAY 100635 in MRN from −60 to 120 min, mirtazapine 10μM in MRN from 0 to 120 min
Open circles in Fig. 4a (control): serotonin level in DRN, no agents
Closed triangles in Fig. 4b (mepyramine 30μM): serotonin level in FC, mepyramine 30μM in DRN from 0 to 120 min
Closed squares in Fig. 4d (mepyramine 100μM): serotonin level in EC, mepyramine 100μM in MRN from 0 to 120 min
Closed triangles in Fig. 5b (methylhistaprodifen 10μM): serotonin level in FC, methylhistaprodifen 10μM in DRN from 0 to 120 min